Cochran C, et al. (1998) Cetyl Myristoleate - A Unique Natural Compound Valuable in Arthritis Conditions. Townsend Letter for Doctors and Patients.
De Keyser, F, et al. Gut inflammation and spondyloarthropathies. Current Rheumatology Reports 4(6):525-532 (2002). Spondyloarthropathies (SpA) are a related group of arthritic conditions which include ankylosing spondylitis, reactive arthritis, psoriatic arthritis and arthritis associated with inflammatory bowel disease. SpA have been correlated with gut inflammation and are immunologically related Crohn's disease. Colostrum's ability to control gut inflammation and modulate the activity of TNF-a indicate that it may be of benefit in SpA treatment.
Feldmann M, Brennan F, Maini R. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology. 14:397-440, 1996.
Grohn, P.; Anttila ,R.; Krohn, K. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis. Scandinavian Journal of Rheumatology 5(3):151-157 (1976).
Hayashida, K, Kaneko, T, Takeuchi, T, Shimizu, H, Ando, K, Harada, E. (2004). Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. Journal of Veterinary Medical Science 66(2):149-54. Lactoferrin is an immunomodulator and has also been found to produce micro-opioid receptor-mediated analgesia. In an rat experimental arthritis model, bovine lactoferrin suppressed the development of the arthritis and lessened the pain (as determined by hyperalgesia of the infected paw). Lactoferrin also suppressed TNF-alpha (pro-inflammatory) production and increased IL-10 (anti-inflammatory) production. Thus lactoferrin has both preventive and therapeutic effects on both the inflammation and pain associated with arthritis.
Hraba, T, Wieczorek, Z, Janusz, M, Lisowski, J, Zimecki, M. Effect of proline-rich polypeptide on experimental autoimmune response to erythrocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 34(4):437-443 (1986).
Jenkins, R. T.; et al. "Increased Intestinal Permeability in Patients with Rheumatoid Arthritis: A Side Effect of Oral Non-Steroidal Anti-inflammatory Drug Therapy," Br. J. Rheumatology. 26(2):10-37, 1987.
Nitsch, A, Nitsch, FP. Clinical use of bovine colostrum. Journal of Orthomolecular Medicine 13(2) (1998). A colostrum preparation was used clinically to treat rheumatoid arthritis and osteoarthritis with good results.
Op. cit., Fallanc, L., p. 192. Feldmann, M.; Brennan, F.; Maini, R. Role of Cytokines in rheumatoid arthritis. Annals of Review in Immunology. 14:397-440, 1996.
Lawrence, HS. Transfer factor and autoimmune disease. Annals of the New York Academy of Science 124(1):56-60 (1965).
Sokal, I, Janusz, M, Miecznikowska, H, Kupryszewski, G, Lisowski, J. Effect of colostrinin, an immunomodulatory proline-rich polypeptide from ovine colostrum, on sialidase and beta-galactosidase activities in murine thymocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 46(3):193-198 (1998).